Cargando…

Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting

BACKGROUND: Informed consent is an ethical and legal requirement for research involving human participants. However, few studies have evaluated the process, particularly in Africa. Participants in a case control study designed to identify correlates of immune protection against tuberculosis (TB) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnies, Deon, Hawkridge, Tony, Hanekom, Willem, Ehrlich, Rodney, London, Leslie, Hussey, Greg
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575196/
https://www.ncbi.nlm.nih.gov/pubmed/18826637
http://dx.doi.org/10.1186/1472-6939-9-15
_version_ 1782160304127344640
author Minnies, Deon
Hawkridge, Tony
Hanekom, Willem
Ehrlich, Rodney
London, Leslie
Hussey, Greg
author_facet Minnies, Deon
Hawkridge, Tony
Hanekom, Willem
Ehrlich, Rodney
London, Leslie
Hussey, Greg
author_sort Minnies, Deon
collection PubMed
description BACKGROUND: Informed consent is an ethical and legal requirement for research involving human participants. However, few studies have evaluated the process, particularly in Africa. Participants in a case control study designed to identify correlates of immune protection against tuberculosis (TB) in South Africa. This study was in turn nested in a large TB vaccine efficacy trial. The aim of the study was to evaluate the quality of consent in the case control study, and to identify factors that may influence the quality of consent. Cross-sectional study conducted over a 4 month period. METHODS: Consent was obtained from parents of trial participants. These parents were asked to complete a questionnaire that contained questions about the key elements of informed consent (voluntary participation, confidentiality, the main risks and benefits, etc.). The recall (success in selecting the correct answers) and understanding (correctness of interpretation of statements presented) were measured. RESULTS: The majority of the 192 subjects interviewed obtained scores greater than 75% for both the recall and understanding sections. The median score for recall was 66%; interquartile range (IQR) = 55%–77% and for understanding 75% (IQR = 50%–87%). Most (79%) were aware of the risks and 64% knew that they participated voluntarily. Participants who had completed Grade 7 at school and higher were more likely (OR = 4.94; 95% CI = 1.57 – 15.55) to obtain scores greater than 75% for recall than those who did not. Participants who were consented by professional nurses who had worked for more than two years in research were also more likely (OR = 2.62; 95% CI = 1.35–5.07) to obtain such scores for recall than those who were not. CONCLUSION: Notwithstanding the constraints in a developing country, in a population with low levels of literacy and education, the quality of informed consent found in this study could be considered as building blocks for establishing acceptable standards for public health research. Education level of respondents and experience of research staff taking the consent were associated with good quality informed consent.
format Text
id pubmed-2575196
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25751962008-10-30 Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting Minnies, Deon Hawkridge, Tony Hanekom, Willem Ehrlich, Rodney London, Leslie Hussey, Greg BMC Med Ethics Research Article BACKGROUND: Informed consent is an ethical and legal requirement for research involving human participants. However, few studies have evaluated the process, particularly in Africa. Participants in a case control study designed to identify correlates of immune protection against tuberculosis (TB) in South Africa. This study was in turn nested in a large TB vaccine efficacy trial. The aim of the study was to evaluate the quality of consent in the case control study, and to identify factors that may influence the quality of consent. Cross-sectional study conducted over a 4 month period. METHODS: Consent was obtained from parents of trial participants. These parents were asked to complete a questionnaire that contained questions about the key elements of informed consent (voluntary participation, confidentiality, the main risks and benefits, etc.). The recall (success in selecting the correct answers) and understanding (correctness of interpretation of statements presented) were measured. RESULTS: The majority of the 192 subjects interviewed obtained scores greater than 75% for both the recall and understanding sections. The median score for recall was 66%; interquartile range (IQR) = 55%–77% and for understanding 75% (IQR = 50%–87%). Most (79%) were aware of the risks and 64% knew that they participated voluntarily. Participants who had completed Grade 7 at school and higher were more likely (OR = 4.94; 95% CI = 1.57 – 15.55) to obtain scores greater than 75% for recall than those who did not. Participants who were consented by professional nurses who had worked for more than two years in research were also more likely (OR = 2.62; 95% CI = 1.35–5.07) to obtain such scores for recall than those who were not. CONCLUSION: Notwithstanding the constraints in a developing country, in a population with low levels of literacy and education, the quality of informed consent found in this study could be considered as building blocks for establishing acceptable standards for public health research. Education level of respondents and experience of research staff taking the consent were associated with good quality informed consent. BioMed Central 2008-09-30 /pmc/articles/PMC2575196/ /pubmed/18826637 http://dx.doi.org/10.1186/1472-6939-9-15 Text en Copyright © 2008 Minnies et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Minnies, Deon
Hawkridge, Tony
Hanekom, Willem
Ehrlich, Rodney
London, Leslie
Hussey, Greg
Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
title Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
title_full Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
title_fullStr Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
title_full_unstemmed Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
title_short Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
title_sort evaluation of the quality of informed consent in a vaccine field trial in a developing country setting
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575196/
https://www.ncbi.nlm.nih.gov/pubmed/18826637
http://dx.doi.org/10.1186/1472-6939-9-15
work_keys_str_mv AT minniesdeon evaluationofthequalityofinformedconsentinavaccinefieldtrialinadevelopingcountrysetting
AT hawkridgetony evaluationofthequalityofinformedconsentinavaccinefieldtrialinadevelopingcountrysetting
AT hanekomwillem evaluationofthequalityofinformedconsentinavaccinefieldtrialinadevelopingcountrysetting
AT ehrlichrodney evaluationofthequalityofinformedconsentinavaccinefieldtrialinadevelopingcountrysetting
AT londonleslie evaluationofthequalityofinformedconsentinavaccinefieldtrialinadevelopingcountrysetting
AT husseygreg evaluationofthequalityofinformedconsentinavaccinefieldtrialinadevelopingcountrysetting